Ask the expert: Can environmental factors cause Parkinson’s?
Author: Saskia MairPublished: 11 June 2020
Prep: Cook: Serves:
In the latest in our ‘Ask the expert’ series, neurologist Dr Ray Dorsey discusses how “the rise of Parkinson’s may be largely human-made”, the risk of certain pesticides – and why he thinks activism is crucial to changing the course of the condition
How are environmental factors linked to Parkinson’s?
The rise of Parkinson’s may be largely human-made. The condition is tied to several environmental factors, including certain pesticides, industrial solvents, heavy metals, and air pollution. The evidence for the link is strongest for certain pesticides, like paraquat, but industrial solvents, like trichloroethylene (TCE), are also likely major contributors. Air pollution has been less studied but could also be influential.
Do we know why pesticides are linked to Parkinson’s?
Many pesticides are nerve toxins, targeting the parts of cells that are known to be damaged in Parkinson’s, and dissolve in fat, which is the principal make-up of the brain. When you give some of these pesticides to mice and rats, they get Parkinson’s.
Were you surprised by the significance of environmental factors when working on your book, ‘Ending Parkinson’s Disease’?
Yes. I knew about the link between pesticides and Parkinson’s, but I did not know the extent of the evidence, and the strength of the relationship between them. I also didn’t know that chemicals like TCE are the most common contaminant of water found underground and contaminate thousands of sites around the US – including one 15 minutes from my home in suburban Rochester, New York.
Who is most at risk of being affected by pesticides?
Numerous studies suggest that farmers are at a 50 to 200% increased risk, and that residents of rural areas and drinkers of well water are also at higher risk. A registry of Parkinson’s in Nebraska, US, has shown the rates of the condition in the country’s rural areas are two to four times higher than in urban areas like Omaha.
Globally, the areas of the world that are most industrialised, like the US and western Europe, have the highest rates of the condition. Areas that are least industrialised, such as sub-Saharan Africa, have the lowest rates, and those that are going through the most rapid industrialisation, like China, have the highest rates of increase.
However, we have been unwilling to invest in these areas to our collective detriment.
Do you have any advice for readers who are concerned about the impact of environmental factors on their health?
Read our book. We wrote it for you – not for researchers – and it is dedicated to those who bear the burden of the condition. All of its authors are devoting the proceeds to efforts to end Parkinson’s. We have a limited number of copies available for free if cost is an issue – email us at info@endingPD.org to find out more.
The best way to change the course of Parkinson’s is activism from those most affected. A March of Dimes changed the course of polio, activism prevented millions of us from being infected with HIV, and ribbons have raised awareness for breast cancer. We need to end the silence on Parkinson’s.
Need to know: Dr Ray Dorsey
Dr Ray Dorsey is David M Levy Professor of Neurology and Director at the Center for Health + Technology at the University of Rochester Medical Center, US, which has conducted more than 100 clinical trials – including trials that led to the approval of four Parkinson’s medications. He recently co-wrote the book,‘Ending Parkinson’s Disease: A Prescription for Action’.
Environmental factors and Parkinson’s
Researchers believe that a combination of genetic and environmental factors can cause Parkinson’s. Chemicals, viruses, bacteria and heavy metals have all been linked to the condition – this could be because they may cause neurons that produce dopamine to die. Scientists have also suggested a connection between herbicides and pesticides, and Parkinson’s.
To find out more about the causes of Parkinson’s, please visit the EPDA website.
Bill Bucklew on walking 2,500 miles for Parkinson’s
Bill Bucklew tells us why he's not afraid of failure
4 days ago
New insights on immune cell process and Parkinson’s disease
Insoluble clumps of the protein alpha-synuclein, which can cause damage to brain cells, have been previously linked to Parkinson’s. Now, scientists in Germany, France and the US have uncovered new details on how brain cells respond to these clusters. The researchers discovered that the brain’s immune cells may be able to join together to break down the protein clumps. According to a press release, this was previously unknown. They also found that these neighbouring cells share mitochondria – structures that generate energy for chemical reactions – to help one another. In certain mutations associated with Parkinson’s, this process may be impaired. The researchers hope this insight could inform the development of new therapies. “We have opened the door to a field that will certainly engage researchers for many years to come,” said Professor Dr Michael Heneka, director of the Department of Neurodegenerative Diseases and Geriatric Psychiatry at the University Hospital…
Could analysing skin oil help diagnose Parkinson’s disease?
Parkinson’s disease patients tend to have high levels of oil, known as sebum, on their skin’s surface. Now, a study has suggested that analysing this substance may help when diagnosing the condition. The study revealed that sebum contains significant amounts of genetic material, specifically the molecule ribonucleic acid (RNA). Analysis of RNA contained in sebum – that is, skin surface lipids RNA, or SSL-RNA – could offer insights into a person’s health. Researchers in Japan examined SSL-RNA in men and women with and without Parkinson’s. The results suggested that the SSL-RNA profiles of those with Parkinson’s had “different characteristics” than those without. The researchers then tested whether examining these profiles with machine learning could reveal those who had Parkinson’s – and who didn’t. The team’s algorithm indicated a “relatively robust discriminatory ability,” supporting the further use of SSL-RNA as part of a future “non-invasive” method for diagnosis.
‘Sonic hedgehog’ protein could impact Parkinson’s disease dyskinesia
Dyskinesia is often caused by extended use of the common Parkinson’s medication levodopa – and can be debilitating for those with the condition. Now, researchers in the US may have found a way to suppress these involuntary movements through a protein called ‘sonic hedgehog’. To conduct their study, the team administered levodopa and sonic hedgehog agonists to rodent and non-human primate models of the condition. The results revealed that dopamine neurons use the protein to communicate with other neurons thought to play a role in levodopa-induced dyskinesia. Increased signalling of sonic hedgehog pathways was found to reduce this dyskinesia – providing “novel insight” into its formation and a “potential therapeutic solution”. “What we find,” wrote corresponding study author Professor Andreas Kottmann, “is that in several animal models, by replacing … dopamine together with agonists that mimic the effects of sonic hedgehog, these dyskinesias can be very much suppressed.”